|[January 03, 2013]
Ranbaxy Laboratories Inc. Implements Cegedim Relationship Management's Compliance Solution Suite to Efficiently Meet Regulatory Requirements
BEDMINSTER, N.J. --(Business Wire)--
Relationship Management today announced that Ranbaxy
Laboratories Inc. has fully deployed the company's groundbreaking
Life Sciences compliance solution suite, including the market leading
AggregateSpend360™, to more efficiently, proactively and successfully
respond to today's compounding regulatory environment. Ranbaxy
Laboratories Inc., a wholly owned subsidiary of Ranbaxy Laboratories
Limited, India's largest pharmaceutical company, is engaged in the sale
and distribution of branded prescription products in the U.S. healthcare
AggregateSpend360 Enables Dramatically Increased Data Visibility and
Features Tailored to Compliance Functionalities
To satisfy the Sunshine Provisions of the Patient Protection and
Affordable Care Act (PPACA), leading Life Sciences companies are
focusing on effectively managing their brands, and connecting with
targets across both pharmacy and prescription channels.
AggregateSpend360 alleviates Ranbaxy's resources and time spent meeting
the PPACA's state/federal aggregate spend and disclosure reporting
requirements. The solution collects and centralizes all transfers of
value to practitioners - rationalizing the data into one customer view
for optimal visibility. The cloud-based solution generates reports
specific to each federal/state regulation. Further, the solution
features unparalleled configuration flexibility to suit Ranbaxy's
distinctive business model needs, fostering cost-effectiveness now and
in the future. AggregateSpend360 fully automates the compliance burden.
Customer Licensure and System Validation Provide Valuable Certainty
of Database Quality and Network Effectiveness
Ranbaxy's compliance solution suite also includes Cegedim's Compliance
ID Powered by OneKey™, which empowers companies to satisfy aggregate
spend and disclosure reporting regulations through verified medical
licensure information sourced from OneKey's database of 12 million
registered HCPs and one million healthcare organizations. Ranbaxy is
also leveraging Cegedim's BuzzeoPDMA compliance knowledge through
Computer Systems Validation Services, which confirm that systems satisfy
both state and federal regulatory standards.
"By aligning with Cegedim's AggregateSpend360 and their compliance
suite, we are staying well ahead of the curve regarding new U.S.
legislation. Teams across the U.S enterprise - Primary Care, KOLs, Home
Office, IT and Compliance teams - are now empowered with the tools to
better track spending, improve data, and ensure that our technology is
fully compliant," said Dr. Ashish Anvekar, Senior Director of Ranbaxy
Laboratories Inc. "Our company can achieve greater focus in providing
patient-centric, quality and value-added pharmaceuticals."
About Cegedim Relationship Management:
Cegedim Relationship Management is the Life Sciences industry's
leading provider of Customer Relationship Management (CRM)
solutions. Designed specifically for Life Sciences, the company's
innovative business solutions incorporate a thorough understanding
of local, regional and worldwide trends. Cegedim Relationship
Management enables more than 200,000 users in many of the world's
most innovative companies to stay ahead of market challenges. In
addition to CRM, Cegedim Relationship Management also provides
marketing, data optimization and regulatory compliance solutions
in more than 80 countries. Cegedim Relationship Management is part
of the France-based Cegedim S.A. Group.
To learn more,
please visit: www.cegedim.com/rm.
Follow Cegedim Relationship Management on LinkedIn
Founded in 1969, Cegedim is a global technology and services
company specializing in the healthcare field. Cegedim supplies
services, technological tools, specialized software, data flow
management services and databases. Its offerings are targeted
notably at healthcare industries, life sciences companies,
healthcare professionals and insurance companies. The world leader
in life sciences CRM, Cegedim is also one of the leading suppliers
of strategic healthcare industry data. Cegedim employs 8,200
people in more than 80 countries and generated revenue of €911
million in 2011. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com.
[ Back To IBM News 's Homepage ]